The George Institute For Global Health
Global
United Kingdom
India
China
Australia

News and Events

Media release: 
31/05/2016

Preliminary findings from a new research program called the   Worker Health and Efficiency (WE) Program reveal that providing Water, Rest and  Shade  (WRS) to workers in extremely hot environments like India can mitigate the ill effects of heat.

Media release: 
24/05/2016

New research from The George Institute for Global Health and the University of Sydney has found that opioid painkillers, a common treatment for low back pain, provide minimal benefit.

Media release: 
23/05/2016

People suffering from heart failure should be given the flu vaccine, according to new research from The George Institute for Global Health.

Media release: 
23/05/2016

A medication used to treat one of the most common causes of kidney failure reduced the risks of kidney function loss or kidney failure by two thirds, according to a new study.

Research by The George Institute for Global Health which revealed paracetamol does not relieve back pain has been highlighted as one of the top 20 studies of 2015 for GPs.

Media release: 
19/05/2016

High blood pressure could significantly raise the risk of developing the second most common form of dementia, according to a new study from The George Institute for Global Health.

Atrial fibrillation is the most common cardiac arrhythmia – a disorder where the person has an irregular heartbeat – and it is growing worldwide. Atrial fibrillation raises the risk of stroke by nearly four times and is associated with a higher risk of death. However, at the moment it is unclear whether atrial fibrillation is associated with a higher risk of other cardiovascular diseases, such as coronary heart disease or peripheral vascular disease (clots in the leg).

Media release: 
11/05/2016

Climate change may be accelerating rates of chronic kidney disease caused by dehydration and heat stress, according to a paper appearing in a recent issue of the prestigious Clinical Journal of the American Society of Nephrology (CJASN).

Media release: 
10/05/2016

The safety of a controversial clot busting drug has been investigated by researchers at The George Institute for Global Health, with results showing a modified dosage can reduce serious bleeding in the brain and improve survival rates.

Helping patients with heart disease to take their medications may be as simple as sending a text or giving them a polypill, researchers at The George Institute for Global Health have found.

Pages